Autres langues Glenmark Pharmaceuticals Limited

Actions

GLENMARK

INE935A01035

Produits pharmaceutiques

Marché Fermé - NSE India S.E. 13:07:19 22/09/2026			Varia. 5j.	Varia. 1 janv.
2 461,40 ^INR	+0,47%		+3,78%	+20,94%

11/09	Glenmark Pharmaceuticals Limited propose un dividende pour l'exercice clos le 31 mars 2026	CI
07/09	Acucort obtient la protection de la marque Zeqmelit en Ukraine	FW

Autres langues

11/09	Glenmark Pharmaceuticals Limited Proposes Dividend for the Year Ended 31 March 2026
04/09	Glenmark Pharmaceuticals Announces Appointment of Priyanka Tewari as Head of Marketing
20/08	Glenmark Pharmaceuticals Limited Receives U.S. FDA Approval For Fluticasone Propionate Nasal Spray 0.05 Mg (50 Mcg)/Spray
31/07	India's Glenmark Pharma posts higher quarterly profit on strong demand
31/07	Glenmark Pharmaceuticals Limited Announces Management Changes, Effective August 1, 2026
31/07	Glenmark Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2026
22/07	Shares in Generic-Drug Makers Fall After Trump's Tariff Plan -- Update
22/07	Shares in Generic-Drug Makers Fall After Trump's Tariff Plan
21/07	Glenmark Pharmaceuticals Unit Gets US FDA Nod for Expanded Use of Ryaltris Nasal Spray
07/07	India finds Adani's Mumbai airport shops sold nicotine pouches in breach of law
06/07	Glenmark Pharmaceuticals Launches Olanzapine for Injection
06/07	Glenmark Pharmaceuticals Inc., USA Launches Olanzapine for Injection, 10 Mg/Vial, Single-Dose Vial
17/06	Glenmark Pharmaceuticals Launches Methylene Blue Injection in US
11/06	Glenmark Pharmaceuticals Unit Launches Acne Treatment Winlevi in European Markets
11/06	Cosmo Pharmaceuticals Flags Launch of Acne Treatment in Key Markets Across Europe
05/06	Indian Equities Slip on Friday After RBI Flags Higher Inflation, Lower Growth Outlook
05/06	Glenmark Pharmaceuticals Launches Generic Seizure Drug in US
01/06	Caring Brands Inks Expanded Five-Year Licensing Deal With SanPellegrino Cosmetics
01/06	Glenmark Pharmaceuticals' Profit Soars in Fiscal Q4
29/05	Glenmark Pharmaceuticals Limited Recommends Dividend for the Financial Year 2025-26
29/05	Glenmark Pharma approves transfer of nebulizer brands/ip portfolio to unit
29/05	Glenmark Pharmaceuticals Limited Announces Executive Changes
29/05	Glenmark Pharma Q4 consol net profit 3.01 billion rupees
29/05	Glenmark Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026
18/05	Glenmark Pharmaceuticals Launches Vancomycin Hydrochloride for Injection in US